Equities Analysts Set Expectations for Pfizer Q4 Earnings
Pfizer Inc. (NYSE:PFE – Free Report) – Research analysts at Zacks Research lowered their Q4 2024 earnings estimates for shares of Pfizer in a research report issued to clients and investors on Monday, November 18th. Zacks Research analyst K. Shah now expects that the biopharmaceutical company will earn $0.39 per share for the quarter, down […]
More Stories
Korro Bio, Inc. (NASDAQ:KRRO) Receives $142.17 Average Price Target from Brokerages
Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) has been assigned a consensus rating of “Buy” from the six ratings...
TD Securities Cuts Talon Metals (TSE:TLO) Price Target to C$0.30
Talon Metals (TSE:TLO – Free Report) had its price target decreased by TD Securities from C$0.55 to C$0.30 in a...
Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM – Free Report) in a report published on Monday morning....
Reading International (NASDAQ:RDI) Now Covered by StockNews.com
StockNews.com began coverage on shares of Reading International (NASDAQ:RDI – Free Report) in a report issued on Monday. The firm...
Symbolic Logic (NASDAQ:EVOL) Now Covered by StockNews.com
StockNews.com started coverage on shares of Symbolic Logic (NASDAQ:EVOL – Free Report) in a research report sent to investors on...
Remark (NASDAQ:MARK) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Remark (NASDAQ:MARK – Free Report) in a research report released on Monday. The firm...